Research & Development
Stealth BioTherapeutics concludes patient enrolment in PMM study
26 April 2019 - Biotechnology company Stealth BioTherapeutics (NASDAQ:MITO) said on Thursday that it has completed the enrolment of patients with primary mitochondrial myopathy in its MMPOWER-3 (SPIMM...
Acutus Medical announces CE mark for new contact mapping software for cardiac ablation treatment
26 April 2019 - Arrhythmia care company Acutus Medical revealed on Thursday that it has obtained CE mark approval in Europe for its AcQMap contact mapping software.The new software offers expanded fun...
CSL Behring awarded US FDA approval for new vial sizes of ZEMAIRA for treating Alpha 1
26 April 2019 - Biotherapeutics company CSL Behring reported on Thursday the receipt of US Food and Drug Administration (FDA) approval in 4- and 5-gram vial sizes for ZEMAIRA [Alpha1-Proteinase Inhibi...
Bausch Health Companies Inc wins US FDA approval for DUOBRII Lotion 0.01%/0.045% for treating plaque psoriasis in adults
26 April 2019 - Healthcare company Bausch Health Companies Inc (NYSE/TSX:BHC) and its Ortho Dermatologics dermatology business reported on Thursday the receipt of approval from the US Food and Drug Ad...
US Bioservices Selected by Biocodex SAS to Exclusively Dispense Diacomit
26 April 2019 - - US-based specialty pharmacy US Bioservices, which a part of AmerisourceBergen, has been selected by Biocodex SAS to exclusively dispense Diacomit (stiripentol), the company said.
Knopp Biosciences Receives FDA Orphan Drug Designation for Dexpramipexole for Treatment of Hypereosinophilic Syndrome
25 April 2019 - - The US Food and Drug Administration has granted Orphan Drug Designation to dexpramipexole, US-based drug discovery and development company Knopp Biosciences LLC's oral drug cand...
Related Headlines

Aveo Oncology to Receive USD 2m Milestone Payment from EUSA Pharma Related To Commercialisation of Fotivda in Spain

Belite Bio wins US FDA approval for LBS-008 IND for macular degeneration and Stargardt disease

Teva Launches Generic Version of VESIcare Tablets in the United States

Prescient Medicine Holdings Inc closes acquisition of AutoGenomics Inc

BAROnova Inc wins US FDA approval for first-in-class, non-surgical solution TPS device for obesity

AliveCor wins US FDA's first-ever clearances to detect the three most common heart arrhythmias

AbbVie wins US FDA clearance for SKYRIZI to treart moderate to severe plaque psoriasis in adults

Boston Scientific awarded US FDA approval for LOTUS Edge Aortic Valve System for safe and effective treatment of severe aortic stenosis

US Food and Drug Administration grants approval to Merck's Keytruda in combination with Inlyta

FDA Approves Merck's Keytruda in Combination with Inlyta as First-Line Treatment for Patients with Advanced Renal Cell Carcinoma

Pfizer and Lilly Release Top-Line Results from Long-Term Phase 3 Study of Tanezumab in Patients with Osteoarthritis

Innovus Pharma Wins FDA Approval of New ANDA for Supply of FlutiCare

Viela Bio Receives US FDA Breakthrough Therapy Designation for Inebilizumab for Treatment of Neuromyelitis Optica Spectrum Disorder

Teva Pharmaceutical launches generic version of VESIcare tablets in the US

US Food and Drug Administration grants Breakthrough Therapy Designation to Viela Bio's inebilizumab